biogen inc said european patent offic grant patent cover certain protein use produc hepat vaccin through genet engin techniqu robert gottlieb biogen spokesman said compani has licens vaccin nonexclus basi british pharmaceut firm and discuss licens with compani biogen said patent give right exclud other from market hepat vaccin member countri european patent convent gottlieb said compani has also file patent market includ vaccin clinic test patent biotechnolog field particular import compani with exclus patent can reap larg reward recent mani product genet engin have target patent lawsuit merck and inc alreadi sell genet engin hepat vaccin call recombivax subsidiari smithklin biolog base belgium sell hepat vaccin call engerix belgium smithklin spokesman said vaccin has also been formal approv switzerland and luxembourg and has been author for market number far east countri hepat serious liver infect common mani part africa and southeast asia about five pct pct popul carri virus about 200 000 new case occur each year last decemb european patent ofic reject biogen patent for alpha interferon which biogen said will appeal onc receiv formal written opinion from offic reuter 